Nirmatrelvir & ritonavir (Paxlovid) - dmd Under review
Metadata
- Coding system
- Dictionary of Medicines and Devices
- Coding system release
- 2023 4.3.0
- Organisation
- OpenSAFELY
- Codelist ID
- opensafely/nirmatrelvir-ritonavir-paxlovid-dmd
- Version ID
- 5251efcf
- Number of codes included
- 2
About
Description
Nirmatrelvir & ritonavir is an antiviral combination product for COVID-19 which is to be made available from community pharmacies. It is commonly known by the brand name _paxlovid_.
Methodology
Converted from pseudo-BNF system codelist
References
Signed off by
- Brian MacKenna, (May 2, 2023)
Codelists are developed by a broad community of users for individual study purposes, which may or may not meet the needs of other studies. They should not be thought of as universal definitions of a particular condition.
We don't offer any guarantees about what they do or don't identify. Users should carefully check that any codelist meets their needs, and seek clinical input where appropriate.
* dm+d codelists can be downloaded with codes mapped to changed VMPs included - this is the default for an OpenSAFELY project. See the documentation on keeping codelists up to date for more details.
| dmd_type | dmd_id | dmd_name | bnf_code |
|---|---|---|---|
| VMP | 40326811000001109 | Nirmatrelvir 150mg tablets and Ritonavir 100mg tablets | 0503060B0AAAAAA |
| AMP | 40325011000001107 | Paxlovid 150mg/100mg tablets | 0503060B0BBAAAA |
* Note that this is the full list of explicitly included dm+d codes for this codelist. An OpenSAFELY project will by default also include previous or subsequent codes for any included VMPs that may have changed code. See the documentation on keeping codelists up to date for more details.